ecrin-mdr-crcClinical2014colorectal cancerColorectal CancerInterventionalhttps://newmdr.ecrin.org/Study/2630776Japan10ECRIN MDRRecruitingfalsePhase II study of Ccr-based dose-control of S-1 in the first-line chemotherapy of S-1/oxaliplatin(SOX)+bevacizumab regimen for advanced colorectal cancerInterventions: Ccr-based dose-control of S-1 in the first-line chemotherapy of S-1/oxaliplatin(SOX)+bevacizumab regimen Primary outcome(s): Adverse events Study Design: Single arm Non-randomized2014-10-152630776JPRN-UMIN000015446